ATE478948T1 - Nichtmenschliches tier mit adam11-gen- unterbrechung - Google Patents
Nichtmenschliches tier mit adam11-gen- unterbrechungInfo
- Publication number
- ATE478948T1 ATE478948T1 AT06768126T AT06768126T ATE478948T1 AT E478948 T1 ATE478948 T1 AT E478948T1 AT 06768126 T AT06768126 T AT 06768126T AT 06768126 T AT06768126 T AT 06768126T AT E478948 T1 ATE478948 T1 AT E478948T1
- Authority
- AT
- Austria
- Prior art keywords
- human animal
- gene disruption
- adam11 gene
- adam11
- disrupted
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 title abstract 3
- 101000777452 Homo sapiens Disintegrin and metalloproteinase domain-containing protein 11 Proteins 0.000 title 1
- 101150014039 ADAM11 gene Proteins 0.000 abstract 2
- 101100054854 Homo sapiens ADAM11 gene Proteins 0.000 abstract 2
- 108700028369 Alleles Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0276—Knock-out vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6489—Metalloendopeptidases (3.4.24)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/035—Animal model for multifactorial diseases
- A01K2267/0356—Animal model for processes and diseases of the central nervous system, e.g. stress, learning, schizophrenia, pain, epilepsy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Environmental Sciences (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Animal Husbandry (AREA)
- Biophysics (AREA)
- Biodiversity & Conservation Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Psychology (AREA)
- Toxicology (AREA)
- Food Science & Technology (AREA)
- Plant Pathology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005204841 | 2005-07-13 | ||
JP2006013862 | 2006-07-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE478948T1 true ATE478948T1 (de) | 2010-09-15 |
Family
ID=37637177
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT06768126T ATE478948T1 (de) | 2005-07-13 | 2006-07-12 | Nichtmenschliches tier mit adam11-gen- unterbrechung |
Country Status (6)
Country | Link |
---|---|
US (1) | US8309792B2 (de) |
EP (1) | EP1908830B1 (de) |
JP (2) | JP5054519B2 (de) |
AT (1) | ATE478948T1 (de) |
DE (1) | DE602006016448D1 (de) |
WO (1) | WO2007007787A1 (de) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000093043A (ja) | 1998-09-21 | 2000-04-04 | Tanabe Seiyaku Co Ltd | Lig−1遺伝子欠損動物 |
US20030005474A1 (en) | 2001-03-29 | 2003-01-02 | Leviten Michael W. | ADAM-like protease disruptions, compositions and methods related thereto |
-
2006
- 2006-07-12 EP EP06768126A patent/EP1908830B1/de active Active
- 2006-07-12 JP JP2007524676A patent/JP5054519B2/ja not_active Expired - Fee Related
- 2006-07-12 WO PCT/JP2006/313862 patent/WO2007007787A1/ja active Application Filing
- 2006-07-12 DE DE602006016448T patent/DE602006016448D1/de active Active
- 2006-07-12 AT AT06768126T patent/ATE478948T1/de not_active IP Right Cessation
- 2006-07-12 US US11/988,619 patent/US8309792B2/en not_active Expired - Fee Related
-
2012
- 2012-05-24 JP JP2012118642A patent/JP2012175980A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
JP2012175980A (ja) | 2012-09-13 |
EP1908830A4 (de) | 2008-10-08 |
DE602006016448D1 (de) | 2010-10-07 |
US8309792B2 (en) | 2012-11-13 |
JP5054519B2 (ja) | 2012-10-24 |
WO2007007787A1 (ja) | 2007-01-18 |
JPWO2007007787A1 (ja) | 2009-01-29 |
EP1908830B1 (de) | 2010-08-25 |
US20100333216A1 (en) | 2010-12-30 |
EP1908830A1 (de) | 2008-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL300935I2 (nl) | guselkumab. | |
BRPI0921243A2 (pt) | fornecimento de história recente com resultados de pesquisa. | |
NL1028948A1 (nl) | Ortho gesubstitueerde aryl- of heteroarylamideverbindingen. | |
NO20051199D0 (no) | Rorhandteringsutstyr. | |
NO20053362L (no) | Syklofuge. | |
ES1061127Y (es) | Jaula para el cultivo acuatico de moluscos. | |
BRPI0911578A2 (pt) | ensaio de acetaminofeno. | |
ATE402610T1 (de) | Legenest für geflügel | |
FI20050625A0 (fi) | Binääriluokkaan perustuva valvonta | |
DE602006016406D1 (de) | Wachstumsfaktormutanten mit verbesserter biologischer aktivität | |
ATE478948T1 (de) | Nichtmenschliches tier mit adam11-gen- unterbrechung | |
ITRM20050185A1 (it) | Imbarcazione ad ingombro riducibile. | |
ES1061956Y (es) | Amoladora-pulidora con aspiracion. | |
FR2891547B1 (fr) | Compositions bitume-polymere. | |
ES1059682Y (es) | Escarpia atornillable simplificada. | |
NO20040947L (no) | Laseanordning for kumlokk. | |
ES1060974Y (es) | Macetero con riego automatico. | |
ES1061263Y (es) | Herradura. | |
ES1061204Y (es) | Rebosadero con embellecedor removible. | |
ITMO20050300A1 (it) | Elettrotermopergamena -- e.t.p. | |
ITPA20050005U1 (it) | Vassoio intelligente. | |
ITVB20050002A1 (it) | Colmo universale | |
ES1059907Y (es) | Cerrojo con enclavamiento automatizado de su movimiento. | |
ES1060781Y (es) | Sarten con borde rebajado. | |
ES1061049Y (es) | Estanteria-libreria con puertas de persiana. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |